$13.27
▲ +3.0% Today
as of Oct 22, 16:49 ET
Last 30 days
Recent Press Releases & News
Kailera Therapeutics Presents New Clinical Data at EASD 2026 Annual Meeting
Kailera Therapeutics Completes Enrollment for Trial of Ribupatide to Treat Obesity
Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection
KLRA earnings at a glance
The options market is pricing a move of about ±42.1% after the report, a range of roughly $7.68 to $18.86 from today's $13.27. Over its last 1 reports the stock rose the next day 1 time and fell 0, moving ±1.9% on average; after the most recent report on May 26, 2026 it moved +1.9%. That means options currently expect more movement than KLRA has typically delivered. Implied volatility is currently 357%. The share price of $13.27 sits near its 52-week low.
Overview
52-week range
$9.76
$28
19% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
+1.9%
100% positive
Latest IV / EM
357%
EM ±42.1% · $10 · Oct 16
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-1.09 | — | — | — | — | financials |
| Tue May 26, 2026 | Mar/2026 | $3650.00 | — | — | — | +1.9% | earnings |
| Mon Jun 30, 2025 | Jun 2025 | $-28947.00 | — | — | — | — | financials |
| Mon Mar 31, 2025 | Mar 2025 | $-17983.00 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | $-121M | $-85M | — | $-31M | $-20M |
| Net income | $-111M | $-79M | — | $-29M | $-18M |
| EPS (diluted) | $-1.09 | $-3650.00 | — | $-28947.00 | $-17983.00 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $130M | $112M | $160M | $101M | $102M |
| Inventory | — | — | — | — | — |
| Total current assets | $929M | $530M | $558M | — | — |
| Total assets | $1.21B | $625M | $692M | — | — |
| Long-term debt | — | — | — | — | — |
| Total liabilities | $93M | $64M | $56M | — | — |
| Total equity | $1.12B | $-432M | $-356M | $-263M | $-235M |
Implied volatility — last 90 days
Sector peers
KLRA earnings FAQ
What is KLRA's expected move for earnings?
Options currently price a move of about ±42.1%, or $5.59 per share either way from $13.27.
How does KLRA stock usually react to earnings?
Across the last 1 reports the average next-day move was ±1.9%, up 1 times and down 0 times.
What is KLRA's implied volatility?
KLRA's at-the-money implied volatility is about 357% based on the latest options snapshot.